Anti-TNFL8/ TNFSF8/ CD153 monoclonal antibody

Anti-TNFL8/ TNFSF8/ CD153 antibody for FACS & in-vivo assay

Target products collectionGo to TNFSF8/TNFSF8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1859-Ab-1/ GM-Tg-hg-MP1859-Ab-2Anti-Human TNFSF8 monoclonal antibodyHuman
GM-Tg-rg-MP1859-Ab-1/ GM-Tg-rg-MP1859-Ab-2Anti-Rat TNFSF8 monoclonal antibodyRat
GM-Tg-mg-MP1859-Ab-1/ GM-Tg-mg-MP1859-Ab-2Anti-Mouse TNFSF8 monoclonal antibodyMouse
GM-Tg-cynog-MP1859-Ab-1/ GM-Tg-cynog-MP1859-Ab-2Anti-Cynomolgus/ Rhesus macaque TNFSF8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1859-Ab-1/ GM-Tg-felg-MP1859-Ab-2Anti-Feline TNFSF8 monoclonal antibodyFeline
GM-Tg-cang-MP1859-Ab-1/ GM-Tg-cang-MP1859-Ab-2Anti-Canine TNFSF8 monoclonal antibodyCanine
GM-Tg-bovg-MP1859-Ab-1/ GM-Tg-bovg-MP1859-Ab-2Anti-Bovine TNFSF8 monoclonal antibodyBovine
GM-Tg-equg-MP1859-Ab-1/ GM-Tg-equg-MP1859-Ab-2Anti-Equine TNFSF8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1859-Ab-1/ GM-Tg-hg-MP1859-Ab-2; GM-Tg-rg-MP1859-Ab-1/ GM-Tg-rg-MP1859-Ab-2;
GM-Tg-mg-MP1859-Ab-1/ GM-Tg-mg-MP1859-Ab-2; GM-Tg-cynog-MP1859-Ab-1/ GM-Tg-cynog-MP1859-Ab-2;
GM-Tg-felg-MP1859-Ab-1/ GM-Tg-felg-MP1859-Ab-2; GM-Tg-cang-MP1859-Ab-1/ GM-Tg-cang-MP1859-Ab-2;
GM-Tg-bovg-MP1859-Ab-1/ GM-Tg-bovg-MP1859-Ab-2; GM-Tg-equg-MP1859-Ab-1/ GM-Tg-equg-MP1859-Ab-2
Products NameAnti-TNFSF8 monoclonal antibody
Formatmab
Target NameTNFSF8
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TNFSF8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TNFL8/ TNFSF8/ CD153 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP1859-Ag-1tumor necrosis factor (ligand) superfamily, member 8 (Tnfsf8) protein
    ORF Viral VectorvGMLP004531human TNFSF8 Lentivirus particle
    ORF Viral VectorpGMLP004531human TNFSF8 Lentivirus plasmid
    ORF Viral VectorpGMLPm000510mouse Tnfsf8 Lentivirus plasmid
    ORF Viral VectorvGMLPm000510mouse Tnfsf8 Lentivirus particle


    Target information

    Target IDGM-MP1859
    Target NameTNFSF8
    Gene ID944,21949,683163,702944,612608,101099756,574056,100051061
    Gene Symbol and SynonymsCD153,CD30L,CD30LG,TNFRSF8,TNFSF8,TNLG3A
    Uniprot AccessionP32971
    Uniprot Entry NameTNFL8_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseLung Cancer
    Gene EnsemblENSG00000106952
    Target ClassificationN/A

    The target: TNFSF8, gene name: TNFSF8, also named as CD153, CD30L, CD30LG, TNLG3A. The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF8/CD30, which is a cell surface antigen and a marker for Hodgkin lymphoma and related hematologic malignancies. The engagement of this cytokine expressed on B cell surface plays an inhibitory role in modulating Ig class switch. This cytokine was shown to enhance cell proliferation of some lymphoma cell lines, while to induce cell death and reduce cell proliferation of other lymphoma cell lines. The pleiotropic biologic activities of this cytokine on different CD30+ lymphoma cell lines may play a pathophysiologic role in Hodgkin's and some non-Hodgkin's lymphomas. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.